Evolus, Inc. (EOLS) SEC filings
EOLS SEC filings moved a median of -1.61% by the close. EOLS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the EOLS overview →
57 measured EOLS SEC filing events.
Where these EOLS SEC filings landedvs 57 measured EOLS SEC filing reactions
| Middle 50% of EOLS SEC filing reactions | -3.36% to +0.84% |
|---|---|
| Median reaction (to close) | -1.61% |
| Measured reactions | 57 |
Point-in-time · zero look-ahead
Half of the 57 EOLS SEC filing events with a measured close landed between -3.36% and +0.84%; 39% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Evolus, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.86% | +6.01% | |
| Form 8-K Evolus, Inc. For: Aug 05 | SEC filing · Form 8-K | -2.86% | +6.01% | |
| Form 8-K Evolus, Inc. For: Aug 03 | SEC filing · Form 8-K | +0.98% | +0.33% | |
| Form 8-K Evolus, Inc. For: Jul 07 | SEC filing · Form 8-K | +0.14% | -2.02% | |
| Form EFFECT Evolus, Inc. | SEC filing · Form EFFECT | -1.92% | -0.15% | |
| Form 8-K Evolus, Inc. For: Jun 11 | SEC filing · Form 8-K | -1.92% | -0.15% | |
| Form S-3 Evolus, Inc. | SEC filing · Form S-3 | -0.38% | +0.60% | |
| Form 10-Q Evolus, Inc. For: Mar 31 | SEC filing · Form 10-Q | +10.34% | +15.61% | |
| Form 8-K Evolus, Inc. For: May 04 | SEC filing · Form 8-K | +10.34% | +15.61% | |
| Form ARS Evolus, Inc. For: Dec 31 | SEC filing · Form ARS | -1.12% | -3.36% | |
| Form DEF 14A Evolus, Inc. For: Jun 11 | SEC filing · Form DEF | -0.75% | -3.36% | |
| Form DEFA14A Evolus, Inc. | SEC filing · Form DEFA14A | -0.75% | -3.36% | |
| Form 8-K Evolus, Inc. For: Mar 13 | SEC filing · Form 8-K | -2.18% | -0.20% | |
| Form 10-K Evolus, Inc. For: Dec 31 | SEC filing · Form 10-K | +8.18% | +5.47% | |
| Form 8-K Evolus, Inc. For: Mar 03 | SEC filing · Form 8-K | +8.18% | +5.47% | |
| Form S-8 Evolus, Inc. | SEC filing · Form S-8 | +8.18% | +5.47% | |
| Form 8-K Evolus, Inc. For: Jan 09 | SEC filing · Form 8-K | -0.35% | +0.18% | |
| Form 10-Q Evolus, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.46% | -6.14% | |
| Form 8-K Evolus, Inc. For: Nov 05 | SEC filing · Form 8-K | -0.46% | -6.14% | |
| Form 8-K Evolus, Inc. For: Sep 08 | SEC filing · Form 8-K | -0.72% | +0.00% | |
| Form 10-Q Evolus, Inc. For: Jun 30 | SEC filing · Form 10-Q | -8.15% | -5.63% | |
| Form 8-K Evolus, Inc. For: Aug 01 | SEC filing · Form 8-K | -8.15% | -5.63% | |
| Form 8-K Evolus, Inc. For: Jun 05 | SEC filing · Form 8-K | -0.94% | -5.02% | |
| Form 8-K Evolus, Inc. For: May 23 | SEC filing · Form 8-K | -5.12% | +0.22% | |
| Evolus Announces Publication of U.S. Pivotal Study for Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels | Press release | -0.21% | +0.63% | |
| Form 10-Q Evolus, Inc. For: Mar 31 | SEC filing · Form 10-Q | -4.57% | -9.51% | |
| Form 8-K Evolus, Inc. For: May 07 | SEC filing · Form 8-K | -4.57% | -9.51% | |
| Form 8-K Evolus, Inc. For: May 05 | SEC filing · Form 8-K | +0.30% | -0.51% | |
| Form ARS Evolus, Inc. For: Dec 31 | SEC filing · Form ARS | -1.20% | -2.83% | |
| Form DEF 14A Evolus, Inc. For: Dec 31 | SEC filing · Form DEF | -1.20% | -2.83% | |
| Form DEFA14A Evolus, Inc. | SEC filing · Form DEFA14A | -1.20% | -2.83% | |
| Form 10-K Evolus, Inc. For: Dec 31 | SEC filing · Form 10-K | -5.03% | -2.28% | |
| Form 8-K Evolus, Inc. For: Mar 04 | SEC filing · Form 8-K | -5.03% | -2.28% | |
| Form S-8 Evolus, Inc. | SEC filing · Form S-8 | -5.03% | -2.28% | |
| Evolus Announces FDA Approval of Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels | Press release | — | +3.05% | |
| Form 8-K Evolus, Inc. For: Jan 21 | SEC filing · Form 8-K | +6.32% | +5.56% | |
| Form 10-Q Evolus, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.70% | -6.36% | |
| Form 8-K Evolus, Inc. For: Nov 06 | SEC filing · Form 8-K | -1.70% | -6.36% | |
| Form S-8 Evolus, Inc. | SEC filing · Form S-8 | -1.70% | -6.36% | |
| Form 10-Q Evolus, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.29% | |
| Form 8-K Evolus, Inc. For: Jul 31 | SEC filing · Form 8-K | +0.00% | +0.29% | |
| Form 8-K Evolus, Inc. For: Jul 01 | SEC filing · Form 8-K | -0.41% | -3.09% | |
| Form 8-K Evolus, Inc. For: Jun 06 | SEC filing · Form 8-K | +0.08% | -3.43% | |
| Form 10-Q Evolus, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.46% | +0.84% | |
| Form 8-K Evolus, Inc. For: May 07 | SEC filing · Form 8-K | +0.46% | +0.84% | |
| Form ARS Evolus, Inc. For: Dec 31 | SEC filing · Form ARS | +1.04% | +1.74% | |
| Form DEF 14A Evolus, Inc. For: Dec 31 | SEC filing · Form DEF | +1.04% | +1.74% | |
| Form DEFA14A Evolus, Inc. | SEC filing · Form DEFA14A | +1.04% | +1.74% | |
| Form 8-K Evolus, Inc. For: Apr 02 | SEC filing · Form 8-K | +0.00% | -1.61% | |
| Form 8-K Evolus, Inc. For: Mar 11 | SEC filing · Form 8-K | -0.07% | +0.00% | |
| Form 10-K Evolus, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.28% | -2.63% | |
| Form 8-K Evolus, Inc. For: Mar 07 | SEC filing · Form 8-K | -1.28% | -2.63% | |
| Form S-8 Evolus, Inc. | SEC filing · Form S-8 | -1.28% | -2.63% | |
| Form 8-K Evolus, Inc. For: Jan 16 | SEC filing · Form 8-K | +0.77% | +13.46% | |
| Form 8-K Evolus, Inc. For: Dec 20 | SEC filing · Form 8-K | -1.23% | -4.54% | |
| Form 10-Q Evolus, Inc. For: Sep 30 | SEC filing · Form 10-Q | -4.87% | -5.51% | |
| Form 8-K Evolus, Inc. For: Nov 07 | SEC filing · Form 8-K | -4.87% | -5.51% |
Keep exploring
More EOLS: earnings → · analyst actions → · EOLS overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Anika Therapeutics Inc. (ANIK) | 275 | +0.07% | 52% |
| Delcath Systems, Inc. (DCTH) | 275 | -0.27% | 42% |
| LivaNova PLC - Ordinary Shares (LIVN) | 275 | +0.04% | 51% |
| Puma Biotechnology Inc (PBYI) | 274 | +0.44% | 55% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.